US Allergy & Asthma

What US Allergy & Asthma does

US Allergy & Asthma is a private, physician-owned allergy, asthma, and immunology medical practice headquartered in Frisco, Texas, with a secondary clinic in Plano, Texas. Founded by Dr. Naveen Sikka, MD, around 2009, the practice delivers a comprehensive specialty service portfolio including traditional allergen immunotherapy (allergy shots, rush and cluster immunotherapy, rapid desensitization), sublingual immunotherapy (SLIT) drops, advanced pulmonary diagnostics (spirometry and FeNO testing), skin/patch/venom/penicillin allergy testing, aspirin desensitization, biologic therapy, and a dedicated state-of-the-art infusion center offering 23 distinct biologic medications for severe asthma, autoimmune disorders, and immune deficiencies. The clinical team comprises two board-certified allergists/immunologists (Dr. Sikka and Dr. Christine Kurien, DO), two physician assistants, an RN, a practice manager, and a front desk coordinator.

The practice generates revenue through insurance-reimbursed professional services: office consultations, diagnostic testing, allergen immunotherapy (multi-year build-up and maintenance phases), and infusion services. It participates as an in-network provider with eight major commercial and government payers (Blue Cross Blue Shield, United Healthcare, Aetna, Cigna, Medicare, Tricare, Scott and White, and UMR). The go-to-market motion is sales-led and direct-to-consumer, relying on patient self-referral, primary care physician referrals, organic social media (Facebook and Instagram), website-driven content marketing through an educational blog, and insurance network participation for patient discovery. The service addresses 17+ allergy, immunology, and respiratory conditions in patients of all ages, with reported patient volume of 1,000+ and an average patient satisfaction rating of 4.9.

Name

US Allergy & Asthma

Legal name

US Allergy and Asthma

Website

https://usallergyandasthma.com

Company type

Private

Founded year

2009

Operating status

Operating

Headcount range

1–10 employees

Short description

US Allergy & Asthma is a private, physician-owned allergy and immunology practice operating clinics in Frisco and Plano, Texas, delivering immunotherapy, biologic infusions, advanced diagnostics, and specialty procedures to patients of all ages under major commercial and government insurance plans.

Ownership category

akta.pro rank

Product category

Allergy, Asthma & Immunology Healthcare Services

NAICS

Ambulatory Health Care Services (621)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Allergy & Immunology Clinics (HLAKAAAA)

akta.pro secondary industries

Asthma & Airway Disease Specialty Care (HLAKAAAC), Allergen Immunotherapy (SCIT/SLIT) Services (HLAKAAAF), Allergy & Immunology Diagnostic Testing Centers (Skin/Challenge/PFT) (HLAKAAAL)

Keywords

• Allergy and immunology care
• Allergist medical practice
• Biologic infusion therapy
• Allergen immunotherapy services
• Asthma and respiratory care

Headquarters

HQ city

Frisco

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Supply Chain, Marketing or Sales, Infrastructure, Technology or R&D, Others

Revenue model

1. Allergy and Immunology Office Visits: Billable office consultations and follow-up appointments for allergy and asthma evaluation, diagnosis, and ongoing management across all age groups.
2. Diagnostic Testing Services: Revenue generated from skin allergy testing, spirometry/FeNO testing, venom allergy testing, penicillin drug testing, chemical patch testing, and oral challenges.
3. Infusion Services: Administration of biologic medications and other infusions for conditions including severe asthma, rheumatoid arthritis, psoriasis, lupus, osteoporosis, and immune deficiencies. Comprehensive list includes Actemra, Benlysta, Cimzia, Cinqair, Evenity, Fasenra, Gamunex-C, Ilumya, IVIG, LEQVIO, Nucala, Ocrevus, Orencia, Prolia, Remicade, Rituxan, Simponi ARIA, Solu-Medrol, Stelara, Tezspire, VPRIV, Xolair, and Zofran.
4. Allergen Immunotherapy: Allergy shots (build-up and maintenance phases) and sublingual drops for long-term desensitization to specific allergens including pollen, dust mites, mold, pet dander, and insect venom.
5. Biologic Therapy: Targeted biologic medications for severe asthma, chronic spontaneous urticaria, rheumatoid arthritis, psoriasis, lupus, osteoporosis, and other chronic inflammatory conditions.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Core offering

US Allergy & Asthma is a physician-owned medical practice that diagnoses and treats allergic, asthmatic, and immunological conditions across all age groups. The practice offers diagnostic testing (skin, patch, venom, drug, spirometry, FeNO), immunotherapy (shots, sublingual drops, rush and cluster protocols), biologic and immunoglobulin infusion therapies, and procedures such as aspirin desensitization, delivered by board-certified allergists at two North Texas clinics with an in-house infusion center.

Product overview

US Allergy & Asthma is a medical practice offering a comprehensive suite of allergy and asthma diagnostic and treatment services. The practice provides immunotherapy-based treatments (including allergy shots, sublingual drops, rush immunotherapy, cluster immunotherapy, and rapid desensitization), advanced diagnostics (spirometry/FeNO testing, skin allergy testing, chemical patch testing, drug testing, venom allergy testing), biologic therapy, infusion services, and specialized procedures like aspirin desensitization and immunoglobulin replacement therapy. The portfolio includes 15 distinct services spanning from traditional allergy shots to advanced biologic infusions, all delivered by board-certified allergists at their Frisco and Plano, TX locations.

Differentiator

Problem solved

Functional benefit

Products and services

• Biologic Therapy Targeted biologic medications for severe asthma, chronic spontaneous urticaria, rheumatoid arthritis, psoriasis, lupus, osteoporosis, and other chronic inflammatory conditions, administered in the in-office infusion center.
• Infusion Services IV or subcutaneous administration of biologic medications for severe asthma, autoimmune disorders, Gaucher disease, primary immune deficiency, rheumatoid arthritis, and other chronic conditions, including Actemra, Benlysta, Cimzia, Cinqair, Evenity, Fasenra, Gamunex-C, Ilumya, IVIG, LEQVIO, Nucala, Ocrevus, Orencia, Prolia, Remicade, Rituxan, Simponi ARIA, Solu-Medrol, Stelara, Tezspire, VPRIV, Xolair, and Zofran.
• Asthma Treatment Comprehensive asthma management including diagnostic testing, trigger identification, medication management, and allergen immunotherapy tailored to the individual needs of patients of all ages.
• Sublingual Drops (SLIT) Sublingual Immunotherapy delivered as drops or tablets placed under the tongue to gradually build tolerance to allergens, offering a non-invasive, at-home alternative to allergy shots.
• Spirometry and FeNO Testing Advanced pulmonary function tests measuring lung airflow (spirometry) and fractional exhaled nitric oxide (FeNO) to diagnose and manage respiratory conditions such as asthma.
• Allergy Shots (Immunotherapy) Traditional allergen immunotherapy injections that gradually desensitize the immune system to specific allergens, administered in build-up and maintenance phases over 3–5 years.
• Rush Immunotherapy Accelerated allergen immunotherapy protocol that enables patients to reach the maintenance dose in a shorter period than traditional immunotherapy.
• Cluster Immunotherapy Accelerated form of allergen immunotherapy that shortens the time required for patients to begin experiencing the benefits of treatment.
• Rapid Allergy Desensitization Technique that enables patients to achieve desensitization to allergens in a shorter period compared with traditional immunotherapy.
• Immunoglobulin Replacement Therapy Regular infusion or subcutaneous injection of immunoglobulins (antibodies) to maintain adequate antibody levels in patients with primary immune deficiencies.
• Chemical Patch Testing Non-invasive diagnostic procedure used to identify allergic contact dermatitis by evaluating skin reactions to specific chemical allergens.
• Skin Allergy Testing Skin-based testing procedures used to identify specific environmental, food, or other allergens causing allergic reactions.
• Aspirin Desensitization Medical procedure that gradually increases a patient's tolerance to aspirin, particularly beneficial for individuals with AERD (Aspirin-Exacerbated Respiratory Disease).
• Penicillin Drug Testing Skin testing and oral challenge procedures used to determine whether a patient has an allergic reaction to penicillin.
• Venom Allergy Testing Diagnostic procedures — including medical history review, skin testing, and blood tests — to determine whether an individual is allergic to insect venom.

Quantifiable outcome

• 4.9 average patient satisfaction rating across verified testimonials

Named customers5 records

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Scale indicators3 records

Recent moves5 records

Expansion highlights3 records

Direct peers

• AllerVie Health: PE-backed national allergy, asthma, and immunology platform operating multiple clinic locations across the southern US including Texas. Offers the same core services (immunotherapy, biologic infusions, diagnostics) and represents both a direct competitor and a potential roll-up acquirer for independent practices like US Allergy & Asthma.
• Aspire Allergy & Sinus: Texas-headquartered allergy and sinus clinic chain offering immunotherapy (including SLIT), biologic infusions, and allergy diagnostics across multiple Texas markets including DFW. Direct competitor with a multi-location retail-clinic model versus US Allergy & Asthma's independent specialty practice.
• Allergy Partners: Largest US network of board-certified allergist practices offering immunotherapy, biologic therapy, and asthma management across 100+ locations. Direct specialty peer with shared clinical model and significantly greater geographic and operational scale.
• Family Allergy & Asthma: Multi-state allergy and asthma practice group providing immunotherapy, biologic injections, and pediatric/adult allergy care. Operates similar physician-led specialty model with comparable service breadth and serves as a benchmark for scaling an independent allergy group.
• Asthma & Allergy Specialists: Independent specialty allergy/asthma practices operating physician-led clinics offering immunotherapy and biologic therapy in regional US markets. Closest operational analog to US Allergy & Asthma's independent specialty model.
• National Allergy & Asthma Centers: Specialty allergy and immunology clinics providing comprehensive allergy testing, immunotherapy, and biologic therapy in select US markets. Independent specialty peer with similar scope of clinical services.

Regional players

• Red River Allergy & Asthma: Texas-based allergy and asthma practice serving North Texas patients with immunotherapy and diagnostic services. Regional peer operating in the same DFW geography and competing for the same patient and referral pool.
• Dallas Allergy & Asthma Center: Long-established Dallas-area allergy and immunology practice serving the broader DFW market including Plano/Frisco. Direct regional competitor with deeper brand recognition in the immediate local market.

Broad incumbents

• ENT & Allergy Associates: Largest ENT and allergy physician group in the US, offering allergy testing, immunotherapy, and biologic treatments alongside ENT services. Broader multispecialty incumbent that overlaps with US Allergy & Asthma's clinical scope but bundles allergy within a larger practice portfolio.
• SENTA (Southern ENT & Allergy): Large physician services platform combining ENT and allergy/immunology specialties across the southeastern US. Broader multispecialty incumbent that competes for allergy referrals in overlapping geographies and represents the consolidator model.

Market position

Strengths1 record

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/usallergyandasthma
• Instagraminstagram.com/usallergy
• LinkedInlinkedin.com/company/us-allergy-asthma

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about US Allergy & Asthma